Temporary Staff

Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
Publications: 

Precision radiogenomics: fusion biopsies to target tumour habitats in vivo.

E-pub date: 31 Mar 2021


Triage-driven diagnosis of Barrett’s esophagus for early detection of esophageal adenocarcinoma using deep learning.

E-pub date: 31 Mar 2021


Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma

E-pub date: 24 Nov 2020


CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

E-pub date: 30 Sep 2020


Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform.

E-pub date: 31 Aug 2020


Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer.

E-pub date: 31 Jul 2020


ctDNA monitoring using patient-specific sequencing and integration of variant reads.

E-pub date: 31 May 2020


Tissue-specific and interpretable sub-segmentation of whole tumour burden on CT images by unsupervised fuzzy clustering.

E-pub date: 01 May 2020


Detection of ctDNA from Dried Blood Spots after DNA Size Selection.

E-pub date: 31 Mar 2020


Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.

E-pub date: 31 Jan 2020


Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients – initial observations.

E-pub date: 01 Jan 2020


Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.

E-pub date: 01 Jan 2020


Multimodality Approaches to Screening for Lung Cancer.

E-pub date: 31 Jul 2019


Sensitive detection of ctDNA in low burden and ‘challenging’ cancers

E-pub date: 01 Jul 2019


Improved ctDNA detection in early stage non-small-cell lung cancer

E-pub date: 01 Jul 2019


Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors

E-pub date: 01 Jul 2019


3D-printed moulds of renal tumours for image-guided tissue sampling in the clinical setting

E-pub date: 31 May 2019


Circulating cell free DNA during chemo-radiotherapy in non-small cell lung cancer patients

E-pub date: 01 Apr 2019


Real-world utility of an amplicon-based next-generation sequencing liquid biopsy for broad molecular profiling in patients with advanced non-small-cell lung cancer

E-pub date: 31 Dec 2018


Prospective clinical validation of the invisionfirst-lung circulating tumor DNA assay for molecular profiling of patients with advanced nonsquamous non–small-cell lung cancer

E-pub date: 31 Dec 2018


Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models.

E-pub date: 31 Oct 2018


Enhanced detection of circulating tumor DNA by fragment size analysis.

E-pub date: 31 Oct 2018


Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients.

E-pub date: 31 Oct 2018


Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients.

E-pub date: 31 Jul 2018


PO-483 Improved sensitivity for non-invasive diagnosis of high-grade serous ovarian cancer

E-pub date: 01 Jul 2018


Analytical validation of InVisionFirst (TM), a liquid biopsy assay for high-sensitivity broad molecular profiling of circulating tumor DNA using plasma samples of cancer patients

E-pub date: 01 Jul 2018


Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

E-pub date: 01 Jun 2018


Technical Note: Extension of CERR for computational radiomics: A comprehensive MATLAB platform for reproducible radiomics research.

E-pub date: 31 May 2018


Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features.

E-pub date: 01 Apr 2018


Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.

E-pub date: 16 Mar 2018


Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.

E-pub date: 15 Mar 2018


Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer.

E-pub date: 01 Jan 2018


Are liquid biopsies a surrogate for tissue EGFR testing?

E-pub date: 01 Jan 2018


Circulating Tumor DNA in Early Stage NSCLC: High Sensitivity Analysis in Low Burden Disease. LUCID Study Update

E-pub date: 01 Nov 2017


Combined FDG and CT Radiomics Features Predict FMISO Uptake in Head and Neck Cancer

E-pub date: 30 Sep 2017


Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.

E-pub date: 17 Jul 2017


Abstract AP27: FEASIBILITY OF MONITORING RESPONSE TO THE PARP INHIBITOR RUCAPARIB WITH TARGETED DEEP SEQUENCING OF CIRCULATING TUMOR DNA (CTDNA) IN WOMEN WITH HIGH GRADE OVARIAN CARCINOMA ON THE ARIEL2 TRIAL

E-pub date: 31 May 2017


CVE: an R package for interactive variant prioritisation in precision oncology.

E-pub date: 25 May 2017


PO-0890: PET-based radiobiological modeling of changes in tumor hypoxia during chemoradiotherapy

E-pub date: 01 May 2017


A pilot study of individualised monitoring of patients with metastatic melanoma using plasma and urine DNA.

E-pub date: 30 Apr 2017


Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA (ctDNA) in metastatic breast cancer.

E-pub date: 30 Apr 2017


Liquid biopsies come of age: towards implementation of circulating tumour DNA.

E-pub date: 01 Apr 2017


Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA.

E-pub date: 01 Apr 2017


A radiobiological model of radiotherapy response and its correlation with prognostic imaging variables.

E-pub date: 31 Mar 2017


Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.

E-pub date: 31 Dec 2016


A phylogenetic latent feature model for clonal deconvolution

E-pub date: 30 Nov 2016


Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.

E-pub date: 31 Oct 2016


Consensus on precision medicine for metastatic cancers: a report from the MAP conference.

E-pub date: 31 Aug 2016


High Jet Multiplicity Physics at the LHC

E-pub date: 01 Aug 2016


Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes.

E-pub date: 06 Jun 2016


WE-AB-202-11: Radiobiological Modeling of Tumor Response During Radiotherapy Based On Pre-Treatment Dynamic PET Imaging Data.

E-pub date: 01 Jun 2016


Search for new phenomena in final states with large jet multiplicities and missing transverse momentum with ATLAS using √s=13 TeV proton–proton collisions

E-pub date: 31 May 2016


The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.

E-pub date: 10 May 2016


CALIBRATE: Intensive profiling of circulating tumour DNA (ctDNA) from patients participating in experimental therapeutics trials including mutational profiles and copy number changes.

E-pub date: 30 Apr 2016


Circulating tumour DNA carrying patient-specific mutations in TP53 as an early response biomarker in relapsed high grade serous ovarian cancer.

E-pub date: 30 Apr 2016


Evaluation of liquid biopsies for molecular profiling and monitoring in non-small cell lung cancer (NSCLC) patients.

E-pub date: 30 Apr 2016


Measurement of four-jet differential cross sections in √s=8 TeV proton-proton collisions using the ATLAS detector

E-pub date: 30 Nov 2015


Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer.

E-pub date: 04 Nov 2015


Summary of the ATLAS experiment’s sensitivity to supersymmetry after LHC Run 1 — interpreted in the phenomenological MSSM

E-pub date: 30 Sep 2015


Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform

E-pub date: 31 Jul 2015


Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform.

E-pub date: 30 Apr 2015


Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.

E-pub date: 01 Apr 2015


Circulating tumor-derived DNA is shorter than somatic DNA in plasma.

E-pub date: 17 Mar 2015


Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.

E-pub date: 01 Feb 2015


Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.

E-pub date: 31 Aug 2014


Proffered Paper: Noninvasive monitoring of tumour mutations and dynamics in circulating DNA of non-small cell lung cancer patients treated with EGFR inhibitors

E-pub date: 01 Jul 2014


PTU-153 The Timing Of Oncogenic Events In The Evolution Of The Oesophageal Adenocarcinoma Genome And Implications For Clinical Diagnostics.

E-pub date: 01 Jun 2014


Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma.

E-pub date: 31 Jan 2014


EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib–Letter.

E-pub date: 01 Nov 2013


Search for new phenomena in final states with large jet multiplicities and missing transverse momentum at √s = 8 TeV proton-proton collisions using the ATLAS experiment

E-pub date: 30 Sep 2013


Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

E-pub date: 01 Sep 2013


Mutant p53 Prolongs NF-kB activation and promotes chronic inflammation and inflammation-associated colorectal cancer

E-pub date: 31 Jul 2013


Circulating tumor DNA to monitor metastatic breast cancer.

E-pub date: 04 Jul 2013


THE CANCER RESEARCH UK (CRUK) FUNDED ICGC OESOPHAGEAL ADENOCARCINOMA PROJECT: MRC RESEARCH CENTRE AND CRUK CAMBRIDGE RESEARCH INSTITUTE

E-pub date: 01 Jun 2013


Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.

E-pub date: 02 May 2013


Circulating tumor DNA as a non-invasive diagnostic and research tool.

E-pub date: 31 Mar 2013


Analysis of circulating tumor DNA to monitor metastatic breast cancer.

E-pub date: 28 Mar 2013


Non-invasive Monitoring of Metastatic Breast Cancer by Circulating Tumour DNA – a Comparison With Circulating Tumour Cells

E-pub date: 01 Jul 2012


Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

E-pub date: 30 May 2012


Toward early-warning detection of gravitational waves from compact binary coalescence

E-pub date: 31 Mar 2012


Measuring single-cell gene expression dynamics in bacteria using fluorescence time-lapse microscopy.

E-pub date: 15 Dec 2011


MicroRNAs as a potential prognostic factor in gastric cancer.

E-pub date: 21 Sep 2011


Depth-dose distribution of proton beams using inelastic-collision cross sections of liquid water

E-pub date: 31 Dec 2010


A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma.

E-pub date: 01 Nov 2010


Accurate molecular classification of renal tumors using microRNA expression.

E-pub date: 01 Sep 2010


Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression.

E-pub date: 31 Aug 2010


Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin.

E-pub date: 01 Jun 2010


Reply to G. Rossi et al

E-pub date: 30 Sep 2009


MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors.

E-pub date: 31 Jul 2009


Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

E-pub date: 20 Apr 2009


MicroRNAs accurately identify cancer tissue origin.

E-pub date: 01 Apr 2008


Accurate prediction of gene feedback circuit behavior from component properties.

E-pub date: 31 Aug 2007


Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

E-pub date: 08 Jun 2007


Oscillations and variability in the p53 system

E-pub date: 30 Apr 2006


Response delays and the structure of transcription networks.

E-pub date: 31 May 2003


Negative autoregulation speeds the response times of transcription networks.

E-pub date: 31 Oct 2002


Triage-driven diagnosis for early detection of esophageal cancer using deep learning

E-pub date: 01 Jan 1970


Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma

E-pub date: 01 Jan 1970


Show all